-
1
-
-
0002839848
-
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens
-
Edited by: Pozzi G, Wells JM. Springer-Verlag (Berlin) and Landes Bioscience (Georgetown, TX)
-
Pozzi G, Oggioni MR, Medaglini D: Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. In In Gram-positive bacteria. Vaccine vehicles for mucosal immunization Edited by: Pozzi G, Wells JM. Springer-Verlag (Berlin) and Landes Bioscience (Georgetown, TX); 1997:35-60.
-
(1997)
Gram-positive Bacteria. Vaccine Vehicles for Mucosal Immunization
, pp. 35-60
-
-
Pozzi, G.1
Oggioni, M.R.2
Medaglini, D.3
-
3
-
-
0033623253
-
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
-
Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L: Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol 2000, 18:1060-1064.
-
(2000)
Nat. Biotechnol.
, vol.18
, pp. 1060-1064
-
-
Beninati, C.1
Oggioni, M.R.2
Boccanera, M.3
Spinosa, M.R.4
Maggi, T.5
Conti, S.6
Magliani, W.7
De Bernardis, F.8
Teti, G.9
Cassone, A.10
Pozzi, G.11
Polonelli, L.12
-
4
-
-
0035989641
-
In situ delivery of passive immunity by lactobacilli producing single-chain antibodies
-
Kruger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, van Dollenweerd C, Ma JK, Hammarström L: In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 2002, 20: 02-706.
-
(2002)
Nat. Biotechnol.
, vol.20
, pp. 702-706
-
-
Kruger, C.1
Hu, Y.2
Pan, Q.3
Marcotte, H.4
Hultberg, A.5
Delwar, D.6
van Dalen, P.J.7
Pouwels, P.H.8
Leer, R.J.9
Kelly, C.G.10
van Dollenweerd, C.11
Ma, J.K.12
Hammarström, L.13
-
5
-
-
0031815046
-
Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine
-
Steidler L, Robinson K, Chamberlain LM, Schofield KM, Remaut E, Le Page RWF, Wells JM: Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 1998, 66: 183-3189.
-
(1998)
Infect. Immun.
, vol.66
, pp. 3183-3189
-
-
Steidler, L.1
Robinson, K.2
Chamberlain, L.M.3
Schofield, K.M.4
Remaut, E.5
Le Page, R.W.F.6
Wells, J.M.7
-
6
-
-
3042659382
-
Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production
-
Bermudez-Humaran LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R, Le Loir Y: Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 2003, 71:1887-1896.
-
(2003)
Infect. Immun.
, vol.71
, pp. 1887-1896
-
-
Bermudez-Humaran, L.G.1
Langella, P.2
Cortes-Perez, N.G.3
Gruss, A.4
Tamez-Guerra, R.S.5
Oliveira, S.C.6
Saucedo-Cardenas, O.7
Montes de Oca-Luna, R.8
Le Loir, Y.9
-
7
-
-
0034714188
-
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
-
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289: 352-1355.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
Neirynck, S.4
Obermeier, F.5
Falk, W.6
Fiers, W.7
Remaut, E.8
-
8
-
-
0037820426
-
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
-
Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003, 21:785-789.
-
(2003)
Nat. Biotechnol.
, vol.21
, pp. 785-789
-
-
Steidler, L.1
Neirynck, S.2
Huyghebaert, N.3
Snoeck, V.4
Vermeire, A.5
Goddeeris, B.6
Cox, E.7
Remon, J.P.8
Remaut, E.9
-
9
-
-
3042559646
-
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii
-
Ricci S, Macchia G, Ruggiero P, Maggi T, Bossù P, Xu L, Medaglini D, Tagliabue A, Hammarström L, Pozzi G, Boraschi D: In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol 2003, 3:15.
-
(2003)
BMC Biotechnol.
, vol.3
, pp. 15
-
-
Ricci, S.1
Macchia, G.2
Ruggiero, P.3
Maggi, T.4
Bossù, P.5
Xu, L.6
Medaglini, D.7
Tagliabue, A.8
Hammarström, L.9
Pozzi, G.10
Boraschi, D.11
-
10
-
-
0033874108
-
Proinflammatory cytokines
-
Dinarello CA: Proinflammatory cytokines. Chest 2000, 118:503-508.
-
(2000)
Chest
, vol.118
, pp. 503-508
-
-
Dinarello, C.A.1
-
11
-
-
3042612676
-
Interleukin-1 receptor antagonist
-
Edited by: Mantovani A, Dinarello CA, Ghezzi P. Oxford: Oxford University Press
-
Mantovani A, Dinarello CA, Ghezzi P: Interleukin-1 receptor antagonist. In In Pharmacology of cytokines Edited by: Mantovani A, Dinarello CA, Ghezzi P. Oxford: Oxford University Press; 2000:91-119.
-
(2000)
Pharmacology of Cytokines
, pp. 91-119
-
-
Mantovani, A.1
Dinarello, C.A.2
Ghezzi, P.3
-
13
-
-
0025225333
-
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
-
Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990, 348:550-552.
-
(1990)
Nature
, vol.348
, pp. 550-552
-
-
Ohlsson, K.1
Bjork, P.2
Bergenfeldt, M.3
Hageman, R.4
Thompson, R.C.5
-
14
-
-
0025852720
-
A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits
-
Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA: A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991, 5:338-343.
-
(1991)
FASEB J.
, vol.5
, pp. 338-343
-
-
Wakabayashi, G.1
Gelfand, J.A.2
Burke, J.F.3
Thompson, R.C.4
Dinarello, C.A.5
-
15
-
-
0025904893
-
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
-
Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 1991, 173:1029-1032.
-
(1991)
J. Exp. Med.
, vol.173
, pp. 1029-1032
-
-
Alexander, H.R.1
Doherty, G.M.2
Buresh, C.M.3
Venzon, D.J.4
Norton, J.A.5
-
16
-
-
0026006260
-
The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome
-
Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991, 163:1177-1184.
-
(1991)
J. Infect. Dis.
, vol.163
, pp. 1177-1184
-
-
Dinarello, C.A.1
-
17
-
-
0029768091
-
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
-
Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996, 93:11008-11013.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 11008-11013
-
-
Hirsch, E.1
Irikura, V.M.2
Paul, S.M.3
Hirsh, D.4
-
18
-
-
0028239555
-
Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
-
Phase III rhIL-1ra Sepsis Syndrome Study Group
-
Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al.: Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994, 271:1836-1843.
-
(1994)
JAMA
, vol.271
, pp. 1836-1843
-
-
Fisher, C.J.1
Dhainaut, J.F.2
Opal, S.M.3
Pribble, J.P.4
Balk, R.A.5
Slotman, G.J.6
Iberti, T.J.7
Rackow, E.C.8
Shapiro, M.J.9
Greenman, R.L.10
-
19
-
-
0032824168
-
Interleukin-1 receptor antagonist gene therapy for arthritis
-
Krishnan BR: Interleukin-1 receptor antagonist gene therapy for arthritis. Curr Opin Mol Ther 1999, 1:454-457.
-
(1999)
Curr. Opin. Mol. Ther.
, vol.1
, pp. 454-457
-
-
Krishnan, B.R.1
-
20
-
-
19144364120
-
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
-
Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, Wright TM: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996, 7:1261-1280.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 1261-1280
-
-
Evans, C.H.1
Robbins, P.D.2
Ghivizzani, S.C.3
Herndon, J.H.4
Kang, R.5
Bahnson, A.B.6
Barranger, J.A.7
Elders, E.M.8
Gay, S.9
Tomaino, M.M.10
Wasko, M.C.11
Watkins, S.C.12
Whiteside, T.L.13
Glorioso, J.C.14
Lotze, M.T.15
Wright, T.M.16
-
21
-
-
0031786230
-
Treatment of rheumatoid arthritis with IL-1 inhibitors
-
Gabay C, Arend WP: Treatment of rheumatoid arthritis with IL-1 inhibitors. Springer Semin Immunopathol 1998, 20: 29-246.
-
(1998)
Springer Semin. Immunopathol.
, vol.20
, pp. 229-246
-
-
Gabay, C.1
Arend, W.P.2
-
22
-
-
0032830997
-
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1 beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro
-
Giannoukakis N, Rudert WA, Ghivizzani SC, Gambotto A, Ricordi C, Trucco M, Robbins PD: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1 beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999, 48:1730-1736.
-
(1999)
Diabetes
, vol.48
, pp. 1730-1736
-
-
Giannoukakis, N.1
Rudert, W.A.2
Ghivizzani, S.C.3
Gambotto, A.4
Ricordi, C.5
Trucco, M.6
Robbins, P.D.7
-
23
-
-
0030899994
-
Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury
-
Yang GY, Davidson BL, Betz AL: Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 1997, 751:181-188.
-
(1997)
Brain Res.
, vol.751
, pp. 181-188
-
-
Yang, G.Y.1
Davidson, B.L.2
Betz, A.L.3
-
24
-
-
0029637087
-
Sporulation: An alternative way of recover recombinant proteins from B.subtilis
-
Maurizi G, Bossù P, Boraschi D, Ulisse E, Tagliabue A, Ruggiero P: Sporulation: an alternative way of recover recombinant proteins from B.subtilis. Biotechnol Bioengineer 1995, 48:197-200.
-
(1995)
Biotechnol. Bioengineer.
, vol.48
, pp. 197-200
-
-
Maurizi, G.1
Bossù, P.2
Boraschi, D.3
Ulisse, E.4
Tagliabue, A.5
Ruggiero, P.6
-
25
-
-
0344140225
-
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
-
Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988, 81:1162-1172.
-
(1988)
J. Clin. Invest.
, vol.81
, pp. 1162-1172
-
-
Okusawa, S.1
Gelfand, J.A.2
Ikejima, T.3
Connolly, R.J.4
Dinarello, C.A.5
-
26
-
-
0033948395
-
On the fate of ingested Bacillus spores
-
Spinosa MR, Braccini T, Ricca E, De Felice M, Morelli L, Pozzi G, Oggioni MR: On the fate of ingested Bacillus spores. Res Microbiol 2000, 151:361-368.
-
(2000)
Res. Microbiol.
, vol.151
, pp. 361-368
-
-
Spinosa, M.R.1
Braccini, T.2
Ricca, E.3
De Felice, M.4
Morelli, L.5
Pozzi, G.6
Oggioni, M.R.7
-
27
-
-
0023810770
-
In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human IL-1β
-
Boraschi D, Nencioni L, Villa L, Censini S, Bossù P, Ghiara P, Presentini R, Perin F, Frasca D, Doria G, Forni G, Musso T, Giovarelli M, Ghezzi P, Bertini R, Besedovsky HO, del Rey A, Sipe JD, Antoni G, Silvestri S, Tagliabue A: In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human IL-1β. J Exp Med 1988, 168:675-686.
-
(1988)
J. Exp. Med.
, vol.168
, pp. 675-686
-
-
Boraschi, D.1
Nencioni, L.2
Villa, L.3
Censini, S.4
Bossù, P.5
Ghiara, P.6
Presentini, R.7
Perin, F.8
Frasca, D.9
Doria, G.10
Forni, G.11
Musso, T.12
Giovarelli, M.13
Ghezzi, P.14
Bertini, R.15
Besedovsky, H.O.16
del Rey, A.17
Sipe, J.D.18
Antoni, G.19
Silvestri, S.20
Tagliabue, A.21
more..
-
28
-
-
0026038897
-
Mechanism of acute toxicity of IL-1β in mice
-
Boraschi D, Villa L, Ghiara P, Tagliabue A, Mengozzi M, Solito E, Parente L, Silvestri S, Van Damme J, Ghezzi P: Mechanism of acute toxicity of IL-1β in mice. Eur Cytokine Netw 1991, 2: 1-67.
-
(1991)
Eur. Cytokine Netw.
, vol.2
, pp. 61-67
-
-
Boraschi, D.1
Villa, L.2
Ghiara, P.3
Tagliabue, A.4
Mengozzi, M.5
Solito, E.6
Parente, L.7
Silvestri, S.8
Van Damme, J.9
Ghezzi, P.10
-
30
-
-
0034663518
-
IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin
-
Fontana MR, Monaci E, Yanqing L, Guoming Q, Duan G, Rappuoli R, Pizza M: IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 2000, 19:75-85.
-
(2000)
Vaccine
, vol.19
, pp. 75-85
-
-
Fontana, M.R.1
Monaci, E.2
Yanqing, L.3
Guoming, Q.4
Duan, G.5
Rappuoli, R.6
Pizza, M.7
-
31
-
-
0034998394
-
Intracellular bacteria as targets and carriers for vaccination
-
Mollenkopf H, Dietrich G, Kaufmann SH: Intracellular bacteria as targets and carriers for vaccination. Biol Chem 2001, 382:521-532.
-
(2001)
Biol. Chem.
, vol.382
, pp. 521-532
-
-
Mollenkopf, H.1
Dietrich, G.2
Kaufmann, S.H.3
-
32
-
-
0028914039
-
Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella
-
Verma NK, Ziegler HK, Stocker BA, Schoolnik GK: Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 1995, 13:235-244.
-
(1995)
Vaccine
, vol.13
, pp. 235-244
-
-
Verma, N.K.1
Ziegler, H.K.2
Stocker, B.A.3
Schoolnik, G.K.4
-
33
-
-
0031887617
-
Effects of the insertion of a nonapeptide from murine IL-1β on the immunogenicity of carrier proteins delivered by live attenuated Salmonella
-
Chen I, Pizza M, Rappuoli R, Newton SM: Effects of the insertion of a nonapeptide from murine IL-1β on the immunogenicity of carrier proteins delivered by live attenuated Salmonella. Arch Microbiol 1998, 169:113-119.
-
(1998)
Arch. Microbiol.
, vol.169
, pp. 113-119
-
-
Chen, I.1
Pizza, M.2
Rappuoli, R.3
Newton, S.M.4
-
35
-
-
0016723687
-
Absorption of intact protein by colonic epithelial cells of the rat
-
Worthington BS, Enwonwu C: Absorption of intact protein by colonic epithelial cells of the rat. Am J Dig Dis 1975, 20: 50-763.
-
(1975)
Am. J. Dig. Dis.
, vol.20
, pp. 750-763
-
-
Worthington, B.S.1
Enwonwu, C.2
-
36
-
-
0025278734
-
Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2
-
Heyman M, Crain-Denoyelle AM, Nath SK, Desjeux JF: Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2. J Cell Physiol 1990, 143:391-395.
-
(1990)
J. Cell Physiol.
, vol.143
, pp. 391-395
-
-
Heyman, M.1
Crain-Denoyelle, A.M.2
Nath, S.K.3
Desjeux, J.F.4
-
37
-
-
0032555584
-
Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells
-
Maksymowych AB, Simpson LL: Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J Biol Chem 1998, 273:21950-21957.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 21950-21957
-
-
Maksymowych, A.B.1
Simpson, L.L.2
-
38
-
-
0034657529
-
Intestinal absorption of peptides through the enterocytes
-
Zvi E, Bendayan M: Intestinal absorption of peptides through the enterocytes. Microsc Res Tech 2000, 49: 46-352.
-
(2000)
Microsc. Res. Tech.
, vol.49
, pp. 346-352
-
-
Zvi, E.1
Bendayan, M.2
-
39
-
-
0037817352
-
Transcytosis: Crossing cellular barriers
-
Tuma PL, Hubbard AL: Transcytosis: crossing cellular barriers. Physiol Rev 2003, 83:871-932.
-
(2003)
Physiol. Rev.
, vol.83
, pp. 871-932
-
-
Tuma, P.L.1
Hubbard, A.L.2
-
40
-
-
17444394445
-
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
-
Bresnihan B, Alvaro-Garcia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P: Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998, 41:2196-204.
-
(1998)
Arthritis Rheum.
, vol.41
, pp. 2196-2204
-
-
Bresnihan, B.1
Alvaro-Garcia, J.M.2
Cobby, M.3
Doherty, M.4
Domljan, Z.5
Emery, P.6
Nuki, G.7
Pavelka, K.8
Rau, R.9
Rozman, B.10
Watt, I.11
Williams, B.12
Aitchison, R.13
McCabe, D.14
Musikic, P.15
-
41
-
-
0033016267
-
Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: Comparison of efficacy in animal models with human clinical data
-
Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D: Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Arthritis Rheum 1999, 42:498-506.
-
(1999)
Arthritis Rheum.
, vol.42
, pp. 498-506
-
-
Bendele, A.1
McAbee, T.2
Sennello, G.3
Frazier, J.4
Chlipala, E.5
McCabe, D.6
-
42
-
-
0028898529
-
Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
-
Casini Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995, 154:2434-2440.
-
(1995)
J. Immunol.
, vol.154
, pp. 2434-2440
-
-
Casini Raggi, V.1
Kam, L.2
Chong, Y.J.3
Fiocchi, C.4
Pizarro, T.T.5
Cominelli, F.6
-
43
-
-
0027386252
-
Suicidal genetic elements and their use in biological containment of bacteria
-
Molin S, Boe L, Jensen LB, Kristensen CS, Givskov M, Ramos JL, Bei AK: Suicidal genetic elements and their use in biological containment of bacteria. Annu Rev Microbiol 1993, 47: 39-166.
-
(1993)
Annu. Rev. Microbiol.
, vol.47
, pp. 139-166
-
-
Molin, S.1
Boe, L.2
Jensen, L.B.3
Kristensen, C.S.4
Givskov, M.5
Ramos, J.L.6
Bei, A.K.7
-
44
-
-
0025855425
-
Production processes of recombinant IL-1β from Bacillus subtilis: Comparison between intracellular and exocellular expression
-
Velati Bellini A, Galli G, Fascetti E, Frascotti G, Branduzzi P, Lucchese G, Grandi G: Production processes of recombinant IL-1β from Bacillus subtilis: comparison between intracellular and exocellular expression. J Biotechnol 1991, 18:177-192.
-
(1991)
J. Biotechnol.
, vol.18
, pp. 177-192
-
-
Velati Bellini, A.1
Galli, G.2
Fascetti, E.3
Frascotti, G.4
Branduzzi, P.5
Lucchese, G.6
Grandi, G.7
-
45
-
-
0031569584
-
Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II
-
Ruggiero P, Bossù P, Macchia G, Del Grosso E, Sabbatini V, Bertini R, Colagrande A, Bizzarri C, Maurizi G, Di Cioccio V, D'Andrea G, Di Giulio A, Frigerio F, Grifantini R, Grandi G, Tagliabue A, Boraschi D: Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II. J Immunol 1997, 158:3881-3887.
-
(1997)
J. Immunol.
, vol.158
, pp. 3881-3887
-
-
Ruggiero, P.1
Bossù, P.2
Macchia, G.3
Del Grosso, E.4
Sabbatini, V.5
Bertini, R.6
Colagrande, A.7
Bizzarri, C.8
Maurizi, G.9
Di Cioccio, V.10
D'Andrea, G.11
Di Giulio, A.12
Frigerio, F.13
Grifantini, R.14
Grandi, G.15
Tagliabue, A.16
Boraschi, D.17
-
46
-
-
0027233124
-
Characterization of the srfA locus of Bacillus subtilis: Only the valine-activating domain of srfA is involved in the establishment of genetic competence
-
van Sinderen D, Galli G, Cosmina P, de Ferra F, Withoff S, Venema G, Grandi G: Characterization of the srfA locus of Bacillus subtilis: only the valine-activating domain of srfA is involved in the establishment of genetic competence. Mol Microbiol 1993, 8:833-841.
-
(1993)
Mol. Microbiol.
, vol.8
, pp. 833-841
-
-
van Sinderen, D.1
Galli, G.2
Cosmina, P.3
de Ferra, F.4
Withoff, S.5
Venema, G.6
Grandi, G.7
-
47
-
-
0014949207
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
-
Lämmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 80-685.
-
(1970)
Nature
, vol.227
, pp. 680-685
-
-
Lämmli, U.K.1
-
48
-
-
0031105133
-
Purification of human recombinant interleukin 1 receptor antagonist proteins upon Bacillus subtilis sporulation
-
Maurizi G, Di Cioccio V, Macchia G, Bossù P, Bizzarri C, Visconti U, Boraschi D, Tagliabue A, Ruggiero P: Purification of human recombinant interleukin 1 receptor antagonist proteins upon Bacillus subtilis sporulation. Protein Expr Purif 1997, 9: 19-227.
-
(1997)
Protein Expr. Purif.
, vol.9
, pp. 219-227
-
-
Maurizi, G.1
Di Cioccio, V.2
Macchia, G.3
Bossù, P.4
Bizzarri, C.5
Visconti, U.6
Boraschi, D.7
Tagliabue, A.8
Ruggiero, P.9
-
49
-
-
0031412632
-
Functional epitope mapping of human interleukin-1β by surface plasmon resonance
-
D'Ettorre C, De Chiara G, Casadei R, Boraschi D, Tagliabue A: Functional epitope mapping of human interleukin-1β by surface plasmon resonance. Eur Cytokine Netw 1997, 8:161-171.
-
(1997)
Eur. Cytokine Netw.
, vol.8
, pp. 161-171
-
-
D'Ettorre, C.1
De Chiara, G.2
Casadei, R.3
Boraschi, D.4
Tagliabue, A.5
-
50
-
-
0028788688
-
Mapping of receptor binding sites on IL-1β by reconstruction of IL-1ra-like domains
-
Boraschi D, Bossù P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasbarro C, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay AR, Frascotti G, Frigerio F, Grifantini R, Grandi G: Mapping of receptor binding sites on IL-1β by reconstruction of IL-1ra-like domains. J Immunol 1995, 155: 719-4725.
-
(1995)
J. Immunol.
, vol.155
, pp. 4719-4725
-
-
Boraschi, D.1
Bossù, P.2
Ruggiero, P.3
Tagliabue, A.4
Bertini, R.5
Macchia, G.6
Gasbarro, C.7
Pellegrini, L.8
Melillo, G.9
Ulisse, E.10
Visconti, U.11
Bizzarri, C.12
Del Grosso, E.13
Mackay, A.R.14
Frascotti, G.15
Frigerio, F.16
Grifantini, R.17
Grandi, G.18
-
51
-
-
0028789085
-
Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1
-
Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G, Del Grosso E, Tagliabue A, Boraschi D: Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol 1995, 147:1852-1861.
-
(1995)
Am. J. Pathol.
, vol.147
, pp. 1852-1861
-
-
Bossù, P.1
Visconti, U.2
Ruggiero, P.3
Macchia, G.4
Muda, M.5
Bertini, R.6
Bizzarri, C.7
Colagrande, A.8
Sabbatini, V.9
Maurizi, G.10
Del Grosso, E.11
Tagliabue, A.12
Boraschi, D.13
|